A kernel method for incorporating information on disease progression in the analysis of survival
From MaRDI portal
Publication:4320765
DOI10.1093/biomet/81.3.527zbMath0812.62100MaRDI QIDQ4320765
Publication date: 15 May 1995
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biomet/81.3.527
survival analysis; kernel method; bias; censored data; dependence; semi-Markov model; consistent estimators; three-state model; auxiliary endpoints; breast cancer clinical trial
62G07: Density estimation
62P10: Applications of statistics to biology and medical sciences; meta analysis
Related Items
Nonparametric estimation of transition probabilities in a two-stage duration model, Properties of A Nonparametric Test for Early Comparison of Treatments in Clinical Trials in the Presence of Surrogate Endpoints, Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests, Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial, Incorporating short‐term outcome information to predict long‐term survival with discrete markers, Using categorical markers as auxiliary variables in log-rank tests and hazard ratio estimation, Some comments on efficiency gains from auxiliary information for right-censored data, Intermediate clinical events, surrogate markers and survival, Landmark estimation of survival and treatment effects in observational studies, Survival Analysis Using Auxiliary Variables Via Multiple Imputation, with Application to AIDS Clinical Trial Data
